4 results match your criteria: "Paris VI University Institute of Cancerology[Affiliation]"
Ann Surg Oncol
October 2019
Department of Digestive Oncology, Georges Pompidou European Hospital, AP-HP, Paris, France.
Background: Recurrence patterns in stage III colon cancer (CC) patients according to molecular markers remain unclear. The objective of the study was to assess recurrence patterns according to microsatellite instability (MSI), RAS and BRAF status in stage III CC patients.
Methods: All stage III CC patients from the PETACC-8 randomized trial tested for MSI, RAS and BRAF status were included.
J Visc Surg
September 2019
Department of Digestive, Oncological, Endocrine, and Hepatic Surgery, and Hepatic Transplantation, Trousseau Hospital, 37000 Tours, France. Electronic address:
Aim Of The Study: Right colonic Diverticulitis (RD) is rare in Europe; few studies have focused on it and its management is not standardised. The aim of this study was to analyse the clinical presentation (complicated, uncomplicated), acute phase management and long-term outcome of RD in western countries.
Patients And Methods: From 2003 to 2017, 93 consecutive patients who presented with RD were retrospectively included at 11 French Hospital Centres.
ANZ J Surg
January 2019
Assistance Publique Hôpitaux de Paris, Medecine Sorbonne University (Paris VI), Paris, France.
Eur J Surg Oncol
October 2018
Medecine Sorbonne University, Assistance Publique Hôpitaux de Paris, Department of Digestive and Hepato-Pancreato-Biliary Surgery, Pitié-Salpêtrière University Hospital, Paris VI University Institute of Cancerology, Paris, France. Electronic address:
Aim: To report the results of surgery for obstructive right colon cancer (ORCC) and to identify risk factors associated with worse outcomes that may help surgeons to choose the best surgical option.
Methods: This is a retrospective national cohort study, including all patients operated on for ORCC from 2000 to 2015. Those treated with colonic stent or symptomatic treatment were excluded.